Copyright ©The Author(s) 2017.
World J Radiol. Oct 28, 2017; 9(10): 389-399
Published online Oct 28, 2017. doi: 10.4329/wjr.v9.i10.389
Figure 3
Figure 3 Prostate specific membrane antigen. Selected images from a [68Ga]PSMA-11-PET/CT study performed prior to therapy in a man with biopsy-proven Gleason 9 prostate adenocarcinoma, a serum PSA of 11.6 ng/mL, and a clinical tumor stage of cT2b. The anterior maximum intensity projection (MIP) image (A) and the axial PET (B), fusion (C), and CT (D) images through the pelvis demonstrate focal activity in a left external iliac lymph node. This appearance is highly suspicious for a lymph node metastasis. Images courtesy of Tom Hope, MD, University of California San Francisco, Department of Radiology. PSMA: Prostate specific membrane antigen; PET/CT: Positron emission tomography/computed tomography.